107 related articles for article (PubMed ID: 10605053)
1. Synthesis of the optical isomers of 4-[1-(4-tert-butylphenyl)-2-oxo- pyrrolidine-4-yl]methyloxybenzoic acid (S-2) and their biological evaluation as antilipidemic agent.
Ohno T; Yano S; Yamada H; Shirasaka T; Yamamoto A; Kobayashi K; Ogawa K
Chem Pharm Bull (Tokyo); 1999 Nov; 47(11):1549-54. PubMed ID: 10605053
[TBL] [Abstract][Full Text] [Related]
2. Effects of a novel antihyperlipidemic agent, S-2E, on the blood lipid abnormalities in homozygous WHHL rabbits.
Ohmori K; Yamada H; Yasuda A; Yamamoto A; Matsuura N; Kiniwa M
Metabolism; 2004 May; 53(5):680-5. PubMed ID: 15131777
[TBL] [Abstract][Full Text] [Related]
3. Anti-hyperlipidemic action of a newly synthesized benzoic acid derivative, S-2E.
Ohmori K; Yamada H; Yasuda A; Yamamoto A; Matsuura N; Kiniwa M
Eur J Pharmacol; 2003 Jun; 471(1):69-76. PubMed ID: 12809954
[TBL] [Abstract][Full Text] [Related]
4. The Novel Lipid-Lowering Drug D-47 Ameliorates Hepatic Steatosis and Promotes Brown/Beige-Like Change of White Adipose Tissue in db/db Mice.
Mizusaki N; Nomura K; Hosooka T; Shiomi M; Ogawa K; Tsunoda T; Tamori Y; Ogawa W
Kobe J Med Sci; 2019 Jun; 65(1):E36-E43. PubMed ID: 31341155
[TBL] [Abstract][Full Text] [Related]
5. Effects of a novel anti-hyperlipidemic agent, S-2E, on blood lipid levels in rats with fructose-induced hypertriglyceridemia.
Ohmori K; Yamada H; Yasuda A; Yamamoto A; Matsuura N; Kiniwa M
Pharmacology; 2004 Dec; 72(4):240-6. PubMed ID: 15539884
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship of 4-substituted benzoic acids and their inhibitory effect on the biosynthesis of fatty acids and sterols.
Ohno T; Ogawa K; Yano S; Fukushima M; Suzuki N; Asao T
Arch Pharm (Weinheim); 2005 Apr; 338(4):147-58. PubMed ID: 15818566
[TBL] [Abstract][Full Text] [Related]
7. A validated chiral LC method for the enantioselective analysis of Levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide on amylose-based stationary phase.
Rao BM; Ravi R; Shyam Sundar Reddy B; Sivakumar S; Gopi Chand I; Praveen Kumar K; Acharyulu PV; Om Reddy G; Srinivasu MK
J Pharm Biomed Anal; 2004 Sep; 35(5):1017-26. PubMed ID: 15336349
[TBL] [Abstract][Full Text] [Related]
8. New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.
Kamiński K; Zagaja M; Rapacz A; Łuszczki JJ; Andres-Mach M; Abram M; Obniska J
Bioorg Med Chem; 2016 Feb; 24(4):606-18. PubMed ID: 26746343
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activities of the optical isomers of (+/-)-4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2- morpholinyl]methyl]benzamide (mosapride).
Morie T; Kato S; Harada H; Yoshida N; Matsumoto J
Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):877-82. PubMed ID: 8020122
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cholinergic affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)- pyrrolidine, 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their iodomethylates.
Dei S; Bellucci C; Buccioni M; Ferraroni M; Gualtieri F; Guandalini L; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
Bioorg Med Chem; 2003 Jul; 11(14):3153-64. PubMed ID: 12818678
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of an optically active, bicyclic 2-pyridone dipeptide mimetic.
Dragovich PS; Zhou R; Prins TJ
J Org Chem; 2002 Feb; 67(3):741-6. PubMed ID: 11856014
[TBL] [Abstract][Full Text] [Related]
12. Interactions between pyrazole derived enantiomers and Chiralcel OJ: Prediction of enantiomer absolute configurations and elution order by molecular dynamics simulations.
Hu G; Huang M; Luo C; Wang Q; Zou JW
J Mol Graph Model; 2016 May; 66():123-32. PubMed ID: 27060893
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, X-ray analysis, and dopamine receptor-modulating activity of mimics of the "C5" hydrogen-bonded conformation in the peptidomimetic 2-oxo-3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-1- pyrrolidineacetamide.
Baures PW; Ojala WH; Gleason WB; Mishra RK; Johnson RL
J Med Chem; 1994 Oct; 37(22):3677-83. PubMed ID: 7966127
[TBL] [Abstract][Full Text] [Related]
14. Conformationally tailored N-[(2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)carbonyl]proline templates as molecular tools for the design of peptidomimetics. Design and synthesis of fibrinogen receptor antagonists.
Stefanic P; Simoncic Z; Breznik M; Plavec J; Anderluh M; Addicks E; Giannis A; Kikelj D
Org Biomol Chem; 2004 May; 2(10):1511-7. PubMed ID: 15136808
[TBL] [Abstract][Full Text] [Related]
15. Optical resolution and absolute configuration of a nonsteroidal antiinflammatory drug, 2-(10,11-dihydro-10-oxodibenzo- [b,f]thiepin-2-yl)propionic acid.
Yamamoto M; Masaki M; Nohira H
Chirality; 1990; 2(4):280-3. PubMed ID: 2083151
[TBL] [Abstract][Full Text] [Related]
16. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
[TBL] [Abstract][Full Text] [Related]
17. Separation, conformation in solution and absolute configuration of ethopropazine enantiomers.
Sinko G; Novak P; Ziher D; Vinković V; Sunjić V; Simeon-Rudolf V
Enantiomer; 2002; 7(2-3):149-56. PubMed ID: 12108633
[TBL] [Abstract][Full Text] [Related]
18. Structural and coordination properties of 1,2-bis(cyclopropyl)-3,4-bis(2,4,6-tri-tert-butylphenyl)-3,4-diphosphinidenecyclobutene prepared by dehydrogenative homocoupling of 3-cyclopropyl-1-(2,4,6-tri-tert-butylphenyl)-1-phosphaallene.
Ito S; Freytag M; Yoshifuji M
Dalton Trans; 2006 Feb; (5):710-3. PubMed ID: 16429175
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, docking, and biological evaluation of novel 1-benzyl-4-(4-(R)-5-sulfonylidene-4,5-dihydro-1H-1,2,4-triazol-3-yl)pyrrolidin-2-ones as potential nootropic agents.
Semenets AP; Suleiman MM; Fedosov AI; Shtrygol SY; Havrylov IO; Mishchenko MV; Kovalenko SM; Georgiyants VA; Perekhoda LO
Eur J Med Chem; 2022 Dec; 244():114823. PubMed ID: 36274278
[TBL] [Abstract][Full Text] [Related]
20. Hypolipidemic alkoxybenzoic acids.
DeVries VG; Moran DB; Allen GR; Riggi SJ
J Med Chem; 1976 Jul; 19(7):946-57. PubMed ID: 940113
[No Abstract] [Full Text] [Related]
[Next] [New Search]
